Pharmacokinetics of Long-Acting Aqueous Nano-/Microsuspensions After Intramuscular Administration in Different Animal Species and Humans—a Review
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics of Long-Acting Aqueous Nano-/Microsuspensions After Intramuscular Administration in Different Animal Species and Humans—a Review
Authors
Keywords
-
Journal
AAPS Journal
Volume 25, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-12-02
DOI
10.1208/s12248-022-00771-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety, Tolerability, Pharmacokinetics, and Acceptability of Oral and Long-Acting Cabotegravir in HIV-Negative Chinese Men
- (2022) Kelong Han et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Model for Long Acting Injectables (Depot Formulation) Based on Pharmacokinetics and Physical Chemical Properties
- (2022) Jaymin C. Shah et al. AAPS Journal
- Linking In Vitro Intrinsic Dissolution Rate and Thermodynamic Solubility with Pharmacokinetic Profiles of Bedaquiline Long-Acting Aqueous Microsuspensions in Rats
- (2021) Vy Nguyen et al. MOLECULAR PHARMACEUTICS
- Impact of Formulation Parameters on In Vitro Release from Long-Acting Injectable Suspensions
- (2021) Quanying Bao et al. AAPS Journal
- Multicompartmental pharmacokinetic evaluation of long‐acting cabotegravir in healthy adults for HIV preexposure prophylaxis
- (2021) Jafar Sadik Shaik et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Multiparametric magnetic resonance imaging to characterize cabotegravir long‐acting formulation depot kinetics in healthy adult volunteers
- (2021) Beat M. Jucker et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV
- (2021) M Neyens et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Challenges and opportunities in the development of complex generic long-acting injectable drug products
- (2021) Matthew N. O'Brien et al. JOURNAL OF CONTROLLED RELEASE
- Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
- (2021) Nagsen Gautam et al. Nature Communications
- A Randomized, Double-Blind, Multicenter, Noninferiority Study Comparing Paliperidone Palmitate 6-Month Versus the 3-Month Long-Acting Injectable in Patients With Schizophrenia
- (2021) Dean Najarian et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Impact of jet pulverization and wet milling techniques on properties of aripiprazole long-acting injection and absorption mechanism research in vivo
- (2021) Xueting Guo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Effect of particle size on in vivo performances of long-acting injectable drug suspension
- (2021) Myoung Jin Ho et al. JOURNAL OF CONTROLLED RELEASE
- Interpreting In Vitro Release Performance from Long-Acting Parenteral Nanosuspensions Using USP-4 Dissolution and Spectroscopic Techniques
- (2020) Nathan D. Rudd et al. MOLECULAR PHARMACEUTICS
- A year-long extended release nanoformulated cabotegravir prodrug
- (2020) Tanmay A. Kulkarni et al. NATURE MATERIALS
- Liquid chromatography tandem mass spectrometry method for determination of fulvestrant in rat plasma and its application to pharmacokinetic studies of a novel fulvestrant microcrystal
- (2020) Guangyi Leng et al. BIOMEDICAL CHROMATOGRAPHY
- Pharmacokinetics, Safety, and Tolerability of a 2-Month Dose Interval Regimen of the Long-Acting Injectable Antipsychotic Aripiprazole Lauroxil: Results From a 44-Week Phase I Study
- (2020) Peter J. Weiden et al. CNS DRUGS
- Pharmacokinetics, safety and tolerability of long‐acting parenteral intramuscular injection formulations of doravirine
- (2020) Ka Lai Yee et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
- (2020) Raphael J Landovitz et al. Lancet HIV
- Activity of a Long-Acting Injectable Bedaquiline Formulation in a Paucibacillary Mouse Model of Latent Tuberculosis Infection
- (2019) Amit Kaushik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Size matters: the importance of particle size in a newly developed injectable formulation for the treatment of schizophrenia
- (2019) Rakesh Jain et al. CNS SPECTRUMS
- Preparation of sterile long-acting injectable medroxyprogesterone acetate microcrystals based on anti-solvent precipitation and crystal habit control
- (2019) Rong Sun et al. Expert Opinion on Drug Delivery
- Creation of a long-acting rilpivirine prodrug nanoformulation
- (2019) James R. Hilaire et al. JOURNAL OF CONTROLLED RELEASE
- Population Pharmacokinetics of Paliperidone Palmitate (Once‐Monthly Formulation) in Japanese, Korean, and Taiwanese Patients With Schizophrenia
- (2019) Hiroko Shimizu et al. Clinical Pharmacology in Drug Development
- Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
- (2018) Tian Zhou et al. BIOMATERIALS
- Intramuscular and subcutaneous drug depot characterization of a long-acting cabotegravir nanoformulation by MALDI IMS
- (2018) M. Reid Groseclose et al. INTERNATIONAL JOURNAL OF MASS SPECTROMETRY
- Microsuspension of fatty acid esters of entecavir for parenteral sustained delivery
- (2018) Myoung Jin Ho et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Rats and rabbits as pharmacokinetic screening tools for long acting intramuscular depots: case study with paliperidone palmitate suspension
- (2018) Harilal Patel et al. XENOBIOTICA
- Creation of a long-acting nanoformulated dolutegravir
- (2018) Brady Sillman et al. Nature Communications
- Long Acting Injectables – Current Perspective and Future Promises
- (2018) komal Chaudhary et al. CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
- Pharmacokinetics and Pharmacodynamics of Cabotegravir, a Long-Acting HIV Integrase Strand Transfer Inhibitor
- (2018) Dario Cattaneo et al. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
- Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
- (2018) Raphael J. Landovitz et al. PLOS MEDICINE
- Aripiprazole Once-Monthly 400 mg: Comparison of Pharmacokinetics, Tolerability, and Safety of Deltoid Versus Gluteal Administration
- (2017) Arash Raoufinia et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Aripiprazole Lauroxil
- (2017) Marjie L. Hard et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Multimodal imaging approach to examine biodistribution kinetics of Cabotegravir (GSK1265744) long acting parenteral formulation in rat
- (2017) Beat M. Jucker et al. JOURNAL OF CONTROLLED RELEASE
- Dose- and Time-dependency of the Toxicity and Pharmacokinetic Profiles of Bedaquiline and Its N-desmethyl Metabolite in Dogs
- (2017) Ilham Smyej et al. TOXICOLOGIC PATHOLOGY
- Comparison of the Local Tolerability to 5 Long-acting Drug Nanosuspensions with Different Stabilizing Excipients, Following a Single Intramuscular Administration in the Rat
- (2017) Ronnie Chamanza et al. TOXICOLOGIC PATHOLOGY
- Long-Acting Antiretrovirals: Where Are We now?
- (2017) Amesika N Nyaku et al. Current HIV/AIDS Reports
- Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial
- (2017) Martin Markowitz et al. Lancet HIV
- Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy
- (2016) Andrew Owen et al. ADVANCED DRUG DELIVERY REVIEWS
- Population Pharmacokinetics of a Novel Once-Every 3 Months Intramuscular Formulation of Paliperidone Palmitate in Patients with Schizophrenia
- (2016) Mats O. Magnusson et al. CLINICAL PHARMACOKINETICS
- Simultaneous magnetic resonance imaging and pharmacokinetic analysis of intramuscular depots
- (2016) Mareike Probst et al. JOURNAL OF CONTROLLED RELEASE
- The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension
- (2016) Nicolas Darville et al. JOURNAL OF CONTROLLED RELEASE
- The promise and pitfalls of long-acting injectable agents for HIV prevention
- (2016) Raphael J. Landovitz et al. Current Opinion in HIV and AIDS
- Long-acting rilpivirine as potential pre-exposure prophylaxis for HIV-1 prevention (the MWRI-01 study): an open-label, phase 1, compartmental, pharmacokinetic and pharmacodynamic assessment
- (2016) Ian McGowan et al. Lancet HIV
- Initiation of aripiprazole once-monthly in patients with schizophrenia
- (2015) Arash Raoufinia et al. CURRENT MEDICAL RESEARCH AND OPINION
- Safety, tolerability and pharmacokinetics of rilpivirine following administration of a long-acting formulation in healthy volunteers
- (2015) R Verloes et al. HIV MEDICINE
- Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3-month formulation in patients with schizophrenia: A phase-1, single-dose, randomized, open-label study
- (2015) Paulien Ravenstijn et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge
- (2015) Chasity D. Andrews et al. Science Translational Medicine
- Modeling the Time Course of the Tissue Responses to Intramuscular Long-acting Paliperidone Palmitate Nano-/Microcrystals and Polystyrene Microspheres in the Rat
- (2015) Nicolas Darville et al. TOXICOLOGIC PATHOLOGY
- Formulation and pharmacology of long-acting rilpivirine
- (2015) Peter E. Williams et al. Current Opinion in HIV and AIDS
- Formulation and pharmacology of long-acting cabotegravir
- (2015) Christine Trezza et al. Current Opinion in HIV and AIDS
- Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy
- (2015) Andrea L. Martinez-Skinner et al. PLoS One
- Physiologic doses of depot-medroxyprogesterone acetate do not increase acute plasma simian HIV viremia or mucosal virus shedding in pigtail macaques
- (2014) Jessica Radzio et al. AIDS
- A Compartmental Pharmacokinetic Evaluation of Long-Acting Rilpivirine in HIV-Negative Volunteers for Pre-Exposure Prophylaxis
- (2014) A G A Jackson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetics and tolerability of paliperidone palmitate injection in Chinese subjects
- (2014) Tianmei Si et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Pharmacokinetics of olanzapine long-acting injection
- (2014) Stephan Heres et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size
- (2014) Donglei Leng et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- GSK1265744 Pharmacokinetics in Plasma and Tissue After Single-Dose Long-Acting Injectable Administration in Healthy Subjects
- (2014) William Spreen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A single-dose, open-label, parallel, randomized, dose-proportionality study of paliperidone after intramuscular injections of paliperidone palmitate in the deltoid or gluteal muscle in patients with schizophrenia
- (2014) Adriaan Cleton et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A Brief Literature and Patent Review of Nanosuspensions to a Final Drug Product
- (2014) William Wei Lim Chin et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Intramuscular Administration of Paliperidone Palmitate Extended-Release Injectable Microsuspension Induces a Subclinical Inflammatory Reaction Modulating the Pharmacokinetics in Rats
- (2014) Nicolas Darville et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Making the Leap from Daily Oral Dosing to Long-Acting Injectables: Lessons from the Antipsychotics
- (2014) Julius F. Remenar MOLECULAR PHARMACEUTICS
- Long-Acting Atypical Antipsychotics: Characterization of the Local Tissue Response
- (2014) Sara Montminy Paquette et al. PHARMACEUTICAL RESEARCH
- Relative bioavailability and safety of aripiprazole lauroxil, a novel once-monthly, long-acting injectable atypical antipsychotic, following deltoid and gluteal administration in adult subjects with schizophrenia
- (2014) Ryan Turncliff et al. SCHIZOPHRENIA RESEARCH
- Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia
- (2013) Malcolm Mitchell et al. CLINICAL THERAPEUTICS
- Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study
- (2013) Suresh Mallikaarjun et al. SCHIZOPHRENIA RESEARCH
- Species Difference of Esterase Expression and Hydrolase Activity in Plasma
- (2012) Fatma Goksin Bahar et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Interstitial Fluid and Lymph Formation and Transport: Physiological Regulation and Roles in Inflammation and Cancer
- (2012) Helge Wiig et al. PHYSIOLOGICAL REVIEWS
- Comparative pharmacokinetics and pharmacodynamics after subcutaneous and intramuscular administration of medroxyprogesterone acetate (25 mg) and estradiol cypionate (5 mg)
- (2011) José Alfredo Sierra-Ramírez et al. CONTRACEPTION
- Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral Formulation
- (2010) G. van 't Klooster et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases
- (2010) Holland C Detke et al. BMC Psychiatry
- Particle size affects the cellular response in macrophages
- (2010) Hua Yue et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Nanocrystal technology, drug delivery and clinical applications
- (2010) Rainer Müller et al. International Journal of Nanomedicine
- Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives
- (2010) Ranjita Shegokar et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages
- (2010) Ari S. Nowacek et al. JOURNAL OF CONTROLLED RELEASE
- Macrophages Recognize Size and Shape of Their Targets
- (2010) Nishit Doshi et al. PLoS One
- Profile of olanzapine long-acting injection for the maintenance treatment of adult patients with schizophrenia
- (2010) Rosaria rosaria di lorenzo Neuropsychiatric Disease and Treatment
- Nanocarriers’ entry into the cell: relevance to drug delivery
- (2009) Hervé Hillaireau et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia
- (2009) Mahesh N. Samtani et al. CLINICAL PHARMACOKINETICS
- Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment
- (2009) Lieven Baert et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Formulation and evaluation of pharmaceutically equivalent parenteral depot suspension of methyl prednisolone acetate
- (2009) J Ali et al. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started